Endometriosis -which I refer to as “the loud silent disease,” because despite painful symptoms it is usually not diagnosed- is the development of uterine-lining tissue outside the uterus commonly on ovaries, fallopian tubes, tissue lining the pelvis and rarely in liver, lung and on surgical scars. With an estimated prevalence of 10% in women, each menstrual cycle affects the endometrial tissue to thicken, break down and bleed causing inflammation, scarring and eventually abnormal adhesion outside uterus.Symptoms may include commonly painful periods (dysmenorrhea), chronic pelvic pain, dyspareunia (painful sexual intercourse), heavy/irregular bleeding and infertility (25-50% of women with endometriosis) leading to considerable loss of quality of life in physical, mental, and social well being. While the aetiology and pathogenesis are unclear, the scientific literature available (PubMed, MEDLINE, Europe PMC, Cochrane Library, EMBASE, MEDLINE, ScienceDirect) on the diagnosis and treatment of endometriosis provide both awareness and future progress.The current therapies are invasive and primarily treat the symptoms of endometriosis with short-term benefit due to recurrence of pain and disease progression. We require new medical therapies understanding the etymology, exploring preventative methods, and personalising treatment options such as:

It seems that the dietary treatment of endometriosis with lifestyle changes is based on the facts, and offers only positive side effects.